Showing 1971-1980 of 3038 results for "".
- Notal Vision Diagnostic Clinic Reports Completion of 6 Million ForeseeHome AMD Home-Monitoring Testshttps://modernod.com/news/notal-vision-diagnostic-clinic-reports-completion-of-6-million-foreseehome-amd-home-monitoring-tests/2476750/Notal Vision announced the completion of 6 million patient tests performed with ForeseeHome, the first FDA-cleared home-monitoring device for patients with intermediate dry age-related macular degeneration (AMD) at risk for developing wet AMD, according to a company news release. ForeseeHo
- One Week Left to Submit Nominations for OWL Awardshttps://modernod.com/news/one-week-left-to-submit-nominations-for-owl-awards/2476721/OWL is accepting nominations for the
- SIFI Announces Expansion in the French Market With Acquisition of Dacudoses and Novoptinehttps://modernod.com/news/sifi-announces-expansion-in-the-french-market-with-acquisition-of-dacudoses-and-novoptine/2479574/Italian ophthalmic company SIFI has announced the acquisition of Dacudoses and Novoptine antiseptic brands in France from Laboratoire Gifrer Barbezat. Terms of the deal were not disclosed. Dacudoses is the leading reimbursed RX brand of the French ophthalmic antiseptic segment, pres
- Novartis Completes Acquisition of Xiidrahttps://modernod.com/news/novartis-completes-acquisition-of-xiidra-bolstering-ophthalmic-portfolio/2476707/Novartis announced that it has completed its acquisition of Xiidra (lifitegrast ophthalmic solution) 5%, the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. In May, Novartis agreed to acquire Xiidr
- Aldeyra Therapeutics Phase 3 SOLACE Trial Fails to Meet Primary Endpoint in Noninfectious Anterior Uveitishttps://modernod.com/news/aldeyra-therapeutics-phase-3-solace-trial-fails-to-meet-primary-endpoint-in-noninfectious-anterior-uveitis/2476691/Aldeyra Therapeutics announced results from the noninfectious anterior uveitis SOLACE trial. Statistical significance was not achieved for the primary or secondary endpoints, due to high rates of disease resolution in vehicle-treated patients, but activity of reproxalap was consistently greater t
- NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFOhttps://modernod.com/news/novabay-pharmaceuticals-appoints-justin-hall-president-and-ceo-and-jason-raleigh-cfo/2476666/NovaBay Pharmaceuticals announced the appointments of Justin Hall as President and Chief Executive Officer, and Jason Raleigh as Chief Financial Officer. Mr. Hall has served as interim President and CEO, and Mr. Raleigh as interim CFO since March 2019. “Justin and Jason have proven their l
- Three-Year Clinical Trial Results Support Iluvien Launch in Europe for Prevention of Relapse in Recurrent Noninfectious Uveitis Affecting the Posterior Segmenthttps://modernod.com/news/three-year-clinical-trial-results-support-iluvien-launch-in-europe-for-prevention-of-relapse-in-recurrent-noninfectious-uveitis-affecting-the-posterior-segment/2476635/Alimera Sciences announced 3-year followup data from the phase 3 clinical trial for Iluvien 190 micrograms intravitreal implant in applicator for the prevention of relapse in recurrent noninfectious uveitis affecting the posterior segment of the eye (NIPU). The data will support the company’s pla
- Novel Approaches to Cataract Surgery are Challenging Phaco; Cost May Determine Their Successhttps://modernod.com/news/novel-approaches-to-cataract-surgery-are-challenging-phaco-cost-may-determine-their-success/2476591/Ultrasonic phacoemulsification (USP) has been the dominant method of cataract surgery globally over the past half century, but novel alternative approaches are attempting to improve or replace it, according to a Market Scope report. These include robotic cataract machines, ultrasonic-less
- Prevent Blindness Issues Call for Nominations for the 2019 Bonnie Strickland Champion for Children’s Vision Awardhttps://modernod.com/news/prevent-blindness-issues-call-for-nominations-for-the-2019-bonnie-strickland-champion-for-childrens-vision-award/2476590/The National Center for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has issued the call for nominations for the fifth annual Bonnie Strickland Champion for Children’s Vision Award. The award recognizes significant efforts by an individual or group of individuals to improve publ
- Colorlite Colorblind Diagnostic and Correction System Now Available in the United Stateshttps://modernod.com/news/colorlite-colorblind-diagnostic-and-correction-system-now-available-in-the-united-states/2476585/The Colorlite Colorblind Diagnostic and Correction System, which has been used in Europe for more than 20 years, is now available in the United States, according to a company news release. </